| [1] |
Okazaki T, Kuroda Y. Aneurysmal subarachnoid hemorrhage: intensive care for improving neurological outcome[J]. J Intensive Care, 2018, 6: 28.
|
| [2] |
范存刚,孙澎,张庆俊. 2012年AHA/ASA《动脉瘤性蛛网膜下腔出血的诊疗指南》解读[J].中华神经医学杂志, 2013, 12(6): 541-544.
|
| [3] |
van Donkelaar CE, Bakker NA, Birks J, et al. Prediction of outcome after aneurysmal subarachnoid hemorrhage[J]. Stroke, 2019, 50(4): 837-844.
|
| [4] |
Nieuwkamp DJ, Setz LE, Algra A, et al. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis[J]. Lancet Neurol, 2009, 8(7): 635-642.
|
| [5] |
le Roux AA, Wallace MC. Outcome and cost of aneurysmal subarachnoid hemorrhage[J]. Neurosurg Clin N Am, 2010, 21(2): 235-246.
|
| [6] |
Greving JP, Wermer MJ, Brown RD Jr, et al. Development of the phases score for prediction of risk of rupture of intracranial aneurysms: a pooled analysis of six prospective cohort studies[J]. Lancet Neurol, 2014, 13(1): 59-66.
|
| [7] |
钟鸣,赵兵.全国高分级动脉瘤性蛛网膜下腔出血诊疗策略高峰论坛纪要[J].中国脑血管病杂志, 2010, 7(2): 112.
|
| [8] |
吴雪海,胡锦,高亮,等.重症神经外科患者的颅内压监测指征与规范化治疗[J].中华急诊医学杂志, 2013, 22(12): 1321-1323.
|
| [9] |
黄清海,刘建民.倡导循证,更新观念,强化资质,推动颅内动脉瘤血管内介入治疗规范化发展——记《颅内动脉瘤血管内介入治疗中国专家共识(2013)》发布[J].中华医学杂志, 2013, 93(39): 3089-3090.
|
| [10] |
Molyneux A, Kerr R, Stratton I, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomized trial[J]. J Stroke Cerebrovasc Dis, 2002, 11(6): 304-314.
|
| [11] |
Darsaut TE, Raymond J. Barrow ruptured aneurysm trial: 3-year results[J]. J Neurosurg, 2013, 119(6): 1642-1644.
|
| [12] |
Vergouwen MD, Vermeulen M, van Gijn J, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: Proposal of a multidisciplinary research group[J]. Stroke, 2010, 41(10): 2391-2395.
|
| [13] |
Otite F, Mink S, Tan CO, et al. Impaired cerebral autoregulation is associated with vasospasm and delayed cerebral ischemia in subarachnoid hemorrhage[J]. Stroke, 2014, 45(3): 677-682.
|
| [14] |
Calviere L, Nasr N, Arnaud C, et al. Prediction of delayed cerebral ischemia after subarachnoid hemorrhage using cerebral blood flow velocities and cerebral autoregulation assessment[J]. Neurocrit Care, 2015, 23(2): 253-258.
|
| [15] |
中华医学会神经外科学分会.脑血管痉挛防治神经外科专家共识[J].中华医学杂志, 2008, 88(31): 2161-2165.
|
| [16] |
李传玉,黄华东,黄海能.改良腰大池持续外引流在治疗动脉瘤栓塞术后脑积水的应用[J].中华神经创伤外科电子杂志, 2019, 5(3): 189-191.
|
| [17] |
Liu GJ, Luo J, Zhang LP, et al. Meta-analysis of the effectiveness and safety of prophylactic use of nimodipine in patients with an aneurysmal subarachnoid haemorrhage[J]. CNS Neurol Disord Drug Targets, 2011, 10(7): 834-844.
|
| [18] |
张永超,郑鑫辉,张振,等. "3H"疗法在动脉瘤性蛛网膜下腔出血临床应用分析[J].中华神经外科疾病研究杂志, 2015, 14(4): 363-364.
|
| [19] |
Tagami T, Kuwamoto K, Watanabe A, et al. Effect of triple-H prophylaxis on global end-diastolic volume and clinical outcomes in patients with aneurysmal subarachnoid hemorrhage[J]. Neurocrit Care, 2014, 21(3): 462-469.
|
| [20] |
Aburto-Murrieta Y, Marquez-Romero JM, Bonifacio-Delgadillo D, et al. Endovascular treatment: balloon angioplasty versus nimodipine intra-arterial for medically refractory cerebral vasospasm following aneurysmal subarachnoid hemorrhage[J]. Vasc Endovascular Surg, 2012, 46(6): 460-465.
|
| [21] |
Rahme R, Jimenez L, Pyne-Geithman GJ, et al. Endovascular management of posthemorrhagic cerebral vasospasm: indications, technical nuances, and results[J]. Acta Neurochir Suppl, 2013, 115: 107-112.
|
| [22] |
Nakamura T, Matsui T, Hosono A, et al. Beneficial effect of selective intra-arterial infusion of Fasudil hydrochloride as a treatment of symptomatic vasospasm following SAH[J]. Acta Neurochir Suppl, 2013, 115: 81-85.
|
| [23] |
李传玉,黄海能,黄华东,等.早期与延迟介入治疗对颅内破裂动脉瘤患者的疗效和DCI发生率的差异[J].中华脑科疾病与康复杂志(电子版), 2019, 9(1): 30-35.
|
| [24] |
Tao C, Fan C, Hu X, et al. The effect of fenestration of the lamina terminalis on the incidence of shunt-dependent hydrocephalus after aneurysmal subarachnoid hemorrhage (FISH): study protocol for a randomized controlled trial[J]. Medicine (Baltimore), 2016, 95(52): e5727.
|
| [25] |
Lim YC, Shim YS, Oh SY, et al. External ventricular drainage before endovascular treatment in patients with aneurysmal subarachnoid hemorrhage in acute period: its relation to hemorrhagic complications[J]. Neurointervention, 2019, 14(1): 35-42.
|
| [26] |
Cagnazzo F, Gambacciani C, Morganti R, et al. Aneurysm rebleeding after placement of external ventricular drainage: a systematic review and meta-analysis[J]. Acta Neurochir (Wien), 2017, 159(4): 695-704.
|
| [27] |
周建新,赵继宗.进一步规范抗菌药物在神经外科医院感染中的应用——解读《神经外科医院感染抗菌药物应用专家共识》[J].中华医学杂志, 2013, 93(5): 321.
|
| [28] |
Alcalá-Cerra G, Paternina-Caicedo á, Díaz-Becerra C, et al. External lumbar cerebrospinal fluid drainage in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis of controlled trials[J]. Neurologia, 2016, 31(7): 431-444.
|
| [29] |
Park S, Yang N, Seo E. The effectiveness of lumbar cerebrospinal fluid drainage to reduce the cerebral vasospasm after surgical clipping for aneurysmal subarachnoid hemorrhage[J]. J Korean Neurosurg Soc, 2015, 57(3): 167-173.
|
| [30] |
Hellingman CA, van den Bergh WM, Beijer IS, et al. Risk of rebleeding after treatment of acute hydrocephalus in patients with aneurysmal subarachnoid hemorrhage[J]. Stroke, 2007, 38(1): 96-99.
|
| [31] |
李传玉,黄海能,黄华东,等.腰大池持续引流治疗aSAH后发生分流依赖性脑积水的影响因素分析[J].中华脑科疾病与康复杂志(电子版), 2019, 9(1): 15-19.
|
| [32] |
Nathan SK, Brahme IS, Kashkoush AI, et al. Risk factors for in-hospital seizures and new-onset epilepsy in coil embolization of aneurysmal subarachnoid hemorrhage[J]. World Neurosurg, 2018, 115: e523-e531.
|
| [33] |
Yang H, Rajah G, Guo A, et al. Pathogenesis of epileptic seizures and epilepsy after stroke[J]. Neurol Res, 2018, 40(6): 426-432.
|
| [34] |
Hoh BL, Nathoo S, Chi YY, et al. Incidence of seizures or epilepsy after clipping or coiling of ruptured and unruptured cerebral aneurysms in the nationwide inpatient sample database: 2002-2007[J]. Neurosurgery, 2011, 69(3): 644-650; discussion 650.
|
| [35] |
Gilmore E, Choi HA, Hirsch LJ, et al. Seizures and CNS hemorrhage: spontaneous intracerebral and aneurysmal subarachnoid hemorrhage[J]. Neurologist, 2010, 16(3): 165-175.
|
| [36] |
Human T, Diringer MN, Allen M, et al. A randomized trial of brief versus extended seizure prophylaxis after aneurysmal subarachnoid hemorrhage[J]. Neurocrit Care, 2018, 28(2): 169-174.
|
| [37] |
Sykes L, Wood E, Kwan J. Antiepileptic drugs for the primary and secondary prevention of seizures after stroke[J]. Cochrane Database Syst Rev, 2010, 1: CD005398.
|
| [38] |
Naidech AM, Kreiter KT, Janjua N, et al. Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage[J]. Stroke, 2005, 36(3): 583-587.
|
| [39] |
Mahaney KB, Brown RD Jr, Torner JC, et al. International study of unruptured intracranial aneurysms. Response[J]. J Neurosurg, 2014, 121(5): 1022-1023.
|
| [40] |
Kang H, Peng T, Qian Z, et al. Impact of hypertension and smoking on the rupture of intracranial aneurysms and their joint effect[J]. Neurol Neurochir Pol, 2015, 49(2): 121-125.
|
| [41] |
Wiebers DO, Whisnant JP, Huston J, et al. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment[J]. Lancet, 2003, 362(9378): 103-110.
|
| [42] |
Mocco J, Brown RD Jr, Torner JC, et al. Aneurysm morphology and prediction of rupture: an international study of unruptured intracranial aneurysms analysis[J]. Neurosurgery, 2018, 82(4): 491-496.
|
| [43] |
Wang HF, Wang DM. Letter: aneurysm morphology and prediction of rupture: an international study of unruptured international aneurysms analysis[J]. Neurosurgery, 2019, 84(5): E287.
|
| [44] |
Xiang J, Tutino VM, Snyder KV, et al. CFD: computational fluid dynamics or confounding factor dissemination? The role of hemodynamics in intracranial aneurysm rupture risk assessment[J]. AJNR Am J Neuroradiol, 2014, 35(10): 1849-1857.
|